Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MediWound Ltd
MDWD | US
13.76
USD-0.06
-0.43%
MDWD | US
Loading StockChartView...
About MediWound Ltd
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
02/06/2026
Close
13.76
Open
13.95
High
13.95
Low
13.54
MediWound Ltd. a biopharmaceutical company develops manufactures and commercializes novel bio-therapeutic and non-surgical solutions for tissue repair and regeneration in United States Europe and internationally. It markets NexoBrid a biopharmaceutical product for the removal of eschar a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005 which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne Israel.
View LessMDWD | US
Risk
57.6
Sharpe
-1.01
Luna's Score
31/100
Recommendation
Sell
Luna says (MDWD | US)
What's Working
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
74.3%1 month
57.6%3 months
46.6%6 months
43.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
10.93
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-6.32
Ent. to rev.
8.56
PEG
-0.07
Other Fundamentals
EBITDA
-14.50M
MarketCap
148.42M
MarketCap(USD)
148.42M
Div. yield
-
Op. margin
-88.56
Erngs. growth
-
Rev. growth
6.10
Ret. on equity
-75.66
Short ratio
13.70
Short perc.
6.28
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
3.56
Range1M
4.02
Range3M
4.59
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.06
Price X volume
1.52M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -6.32 | 0.53 | Cheaper |
| Ent. to Revenue | 8.56 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 10.93 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 46.59 | 72.80 | Lower Risk |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 148.42M | 3.66B | Emerging |
